Accumulation of indoxyl-β-D-Glucuronide in uremic serum: Suppression of its production by oral sorbent and efficient removal by hemodialysis

Nephron

Volumn 74, Issue 1, 1996, Pages 72-78

  Niwa, Toshimitsu ^a   Miyazaki, Takashi ^a   Tsukushi, Saori ^b   Maeda, Kenji ^a   Tsubakihara, Yoshiharu ^c   Owada, Akira ^d   Shiigai, Tatsuo ^d  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Tokai Central Hospital   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Continuous ambulatory peritoneal dialysis; Hemodialysis; Indoxyl sulfate; Indoxyl beta; D< italic> glucuronide; Oral sorbent (AST 120); Uremia

Indexed keywords

GLUCURONIDE; INDOLE DERIVATIVE; SORBENT;

ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; GLUCURONIDATION; HEMODIALYSIS; HUMAN; HUMAN EXPERIMENT; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; UREMIA; URINARY EXCRETION;

ADSORPTION; CARBON; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUCURONATES; HUMANS; INDOLES; MALE; MASS SPECTROMETRY; OXIDES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROTEIN BINDING; RENAL DIALYSIS; UREMIA;

EID: 0029781830     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189284     Document Type: Article

References (16)

1. Bowmer CJ. Lindup WE: Decreaseddrugbind-ing in uraemia: Effect of indoxyl sulphate and the other endogenous substances on the binding of drugs and dyes to human albumin. Bio-chem Pharmacol 1982:31:319-323.
2. Tavarcs-Almcida I, Gulyassy PF. Depner TA. Jarrard EA: Aromatic amino acid metabolites as potential protein binding inhibitors in human urcmic plasma. Biochem Pharmacol 1985:34:2431-2438.
3. Niwa T. Takeda N. Tatcmatsu A, Maeda K: Accumulation of indoxyl sulfate, an inhibitor of drug binding, in uremic serum as demonstrated by internal-surface reverscd-phase liquid chromatography. Clin Chem 1988:34: 2264-2267.
4. Kawashima Y: Study on the uremic protein binding inhibitors as uremic toxin: Toxic effect on crvthroid colony formation, lymphocyte blast formation and renal function. Jpn J Nephrol 1989;31:1151-1161.
5. Lim CF. Bernard BF. de Jong M. Doctor R. Krenning EP. Hennemann G: A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hcpatocvte transport in uremia. J Clin Endocrinol Metab 1993:76:318-324.
6. Niwa T. Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994:124: 96-104.
7. Niwa T. Ise M. Miyazaki T: Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 1994:14:207-212.
8. Niwa T. Yazawa T. Kodama T. Uehara Y. Maeda K, Yamada K: Efficient removal of albumin-bound furancarboxylicacid., an inhibitor of erythropoiesis. by continuous ambulatory peritoneal dialvsis. Nephron 1990;56:241-245.
9. Niwa T. Emoto Y. Maeda K. Uehara Y. Yamada N. Shibata M: Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients. Nephrol Dial Transplant 1991:6:105-109.
10. Niwa T, Yazawa T. Ise M, Sugano M. Kodama T, Uehara Y. Maeda K: Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in scrum of experimental uremic rats. Nephron 1991;57:84-88.
11. Niwa T. Miyazaki T, Hashimoto N. Hayashi H. Ise M. Uehara Y. Maeda K: Suppressed serum and urine levels of indoxyl sulfale by oral sorbent in experimental uremic rats. Am J Nephrol 1992:12:201-206.
12. Kanai F. Takahama T, Yamazaki Z, Idezuki Y. Koide K: EITect of oral sorbent on experimental uremic rats. Jpn J Nephrol 1986:28:1249-1259.
13. Sakai T. Kumano K. Takara S, Kuwao S. Ise M. Sugano M. Uehara Y: Effect of oral sorbent (AST-120) to chronic renal failure (CRF) in rats. Jpn J Nephrol 1989:31:359-365.
14. Yoshida Y. Sakai T, Ise M: Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992:62:305-314.
15. Sanaka T. Sugino N. Teraoka S, Ota K: Therapeutic effects of oral sorbent in undialyzed uremia. Am J Kidney Dis 1988;12:97-103.
16. Agatsuma S. Sekino H. Nagoshi T. Watanabe H: lndoxyl-beta-Z-glucuronidc. the primary emitter of low-level chemiluminescencc in plasma of hemodialysis patients. Clin Chem 1994:40:1580-1586.